The Need by the Numbers

The Treatment Gap

Videos

GID in the News

1/3

GI Dynamics Appoints Vice President of Clinical and Regulatory Affairs

BOSTON and SYDNEY — 4 January 2019 — GI Dynamics® Inc. (ASX:GID), a medical device company that is developing...
1/1

GI Dynamics Announces Extension of the Maturity Date of US $5M Convertible Note with Crystal Amber

BOSTON and SYDNEY – 2 January 2019 – GI Dynamics® Inc. (ASX:GID), a medical device company that is developing...
12/11

GI Dynamics Appoints Chief Financial Officer and Company Secretary

BOSTON and SYDNEY — 11 December 2018 — GI Dynamics®, Inc. (ASX:GID), a medical device company that is developing...
11/27

GI Dynamics Announces Agreement with Apollo Sugar to Study EndoBarrier in India

Trial to focus on reduction of hemoglobin A1c for patients diagnosed with type 2 diabetes and obesity. BOSTON, SYDNEY, HYDERABAD,...